A recent YouGov poll issued by The Association for the Cannabinoid Industry or The ACI has shown overwhelming support regarding the UK’s Food and Standard Agency (FSA) guidance on cannabidiol regulation.
The ACI collaborated with YouGov to commission a poll that demonstrated strong public acceptance of the CBD regulation set forth by the FSA. The survey provided insight into the UK’s usage and awareness of CBD, revealing that 71% of the participants know about CBD, while 16% have bought a CBD product.
ACI Pharmacy Lead Dr. Andy Yates stated the YouGov poll revealed the public are aware of the current CBD regulation and are willing to support future developments by the FSA regarding new measures in the sale and use of the product.
The UK’s CBD regulation
The FSA conducted a review of various CBD products and discovered possible adverse effects on the health of a person consuming the said substance. It ordered businesses to disclose more information about their CBD products and what they contain. CBD businesses only have until March 31, 2021, to comply with the directive.
Advice on CBD safety for vulnerable groups was also given by the FSA, which includes pregnant women. These individuals are warned against taking CBD products. It also strongly suggested a daily limit of 70mg of CBD for healthy adults.
Asked about their level of support, the participants responded positively to the FSA’s decision. An overwhelming 74% of them welcome guidance, while only 8% are opposed to it.
There were 2065 respondents weighted to signify British adults 18 years and above.
However, CBD consumer confidence is a different story. Only 29% of participants are confident that cannabidiol products in the market are tested and labeled correctly. In comparison, 45% said they don’t wholly trust CBD products to have the right information and testing.
Legal & sustainable CBD
The Global CBD Summit is set to take place on March 16-17 in London, where The ACI will stand as a diamond sponsor.
The ACI Founder Steve Moore will be tackling about the association’s vision to make CBD legal and sustainable, which highlights consumer safety as a priority in his upcoming keynote address.
The ACI Regulatory Lead Dr. Parveen Bhatarah will then run a roundtable discussion that will talk about the association’s activities to make the vision a reality.
Dr. Bhatarah stated the regulatory clarity provided by The ACI’s recent statement would be the basis for a trustworthy and legal CBD sector in the UK. She mentioned the public’s positive reception of the FSA guidance denotes the need for leadership as the demand for CBD keeps rising.
CBD has been designated as a “novel food” since January 2019. It previously followed the EU guideline on Novel Food Regulations wherein food items without consumption history before May 1997 will be subjected to auditing before they can be marketed.
The Center for Medical Cannabis (CMC) trialed thirty CBD oil products in the UK. The tests revealed that more than one-third have only less than half of the claimed CBD content. One CBD oil did not have any cannabidiol at all.